Special Considerations

 

Patients with T-cell acute lymphocytic leukemia (ALL), mature B-cell ALL (Burkitt leukemia), or Ph-positive ALL must discuss with the leukemia specialist specific modifications in their treatments that can improve their cure potential.

Prognosis

In general, the cure rate in children with ALL is 70 percent to 80 percent, but may vary based on risk factors (for example the white blood cell count, chromosomal abnormalities, initial response to therapy, etc.).

In adults with ALL, the remission rate with modern regimens is high at 80 percent to 90 percent. However, the cure rate is only 30 percent to 40 percent. The cure rates are higher in T-cell ALL (about 50 percent), in mature B-cell ALL (about 60 percent to 70 percent), and more recently possibly in Ph-positive ALL.

This content was last modified on August 11, 2007 .
Latest Cancer News
“Scent” May Aid in Skin Cancer Diagnosis

August 21, 2008 — The concentration of certain molecules called volatile organic compounds (VOCs) given off by a cancer may ultimately contribute to accurate diagnosis of skin cancer. These results were recently presented at the 2008 annual American Chemical Society meeting.

Livial® Reduces Breast Cancer Risk but Increases Stroke Risk

August 21, 2008 — Livial® (tibolone), an agent used to reduce menopausal symptoms as well as bone loss, significantly reduces the risk of breast cancer and prevents bone loss and fractures in older postmenopausal women; however, it doubles the risk of stroke among postmenopausal women. These results were recently published in the New England Journal of Medicine.

Watchful Waiting Versus Radical Prostatectomy: 11-year Follow-up

August 21, 2008 — Researchers affiliated with the Scandinavian Prostatic Cancer Group Study Number 4 have reported the following: “Radical prostatectomy reduces prostate cancer mortality and risk of metastases with little or no further increase in benefit 10 or more years after surgery.” The details of the 3rd report of this randomized trial appeared in an early online publication in the Journal of the National Cancer Institute on August 11, 2008.

Select news items provided by Reuters Health